Among nine candidate oncogenes, high expression of four genes including RFTN1, HMGB1, RPL24, and RPL31 were reported to be correlated with a poorer prognosis in cancers (conversely, one may say that low expression of such genes shows good prognosis). This evidence concerns the gene HMGB1 and cancer.